Brought to you by 
Insulet raises $35.5mm in fourth round
05 May 2004
Executive Summary
Insulet (disposable insulin delivery system) raised $35.5mm in its Series D private financing, which was led by Alta Partners and joined by other new investors MedVenture Associates, TIAA-CREF, Piper Jaffray ventures, and Diamond Capital Management. Return backers included Pequot Ventures, Versant Ventures, Schroder Ventures Life Sciences, Oakwood Medical Investors and founding investor Prism Venture Partners.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Macromolecule
-
Drug Delivery
-
Medical Devices
- Infusion Therapy Equipment and Supplies
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Insulet raises $35.5mm in fourth round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice